Why a peptide vial freezes in the fridge

A poster on r/Peptides opened a bar fridge that had run too cold and found one vial frozen solid while everything next to it in the same case was still liquid^[9]. The frozen one was BPC-157. The retatrutide and the GHK-Cu were fine. Forum reports are not evidence, but the question underneath this one is real and it has an answer in physical chemistry rather than in anything peculiar to BPC-157.

Freezing point depression is real, and it is small

Dissolved solutes lower the freezing point of the solvent they sit in. The effect is colligative, meaning it tracks how many particles are dissolved rather than what those particles are. One mole of dissolved solute drops the freezing point of a kilogram of water by roughly 1.86 degrees C, which is the relationship clinical laboratories rely on when they measure osmolality by freezing-point osmometry^[1].

Apply that to a reconstituted peptide vial and the numbers shrink fast. A few milligrams of a 15-residue peptide dissolved in a couple of millilitres of solvent is a few micromoles of solute, not a few millimoles. The peptide itself moves the freezing point by a small fraction of one degree. Everything else in the vial does more of the work: the salt and the acetate or trifluoroacetate counterions carried over from synthesis, the benzyl alcohol in bacteriostatic water (covered separately in our piece on bacteriostatic water), and any bulking agent left behind by freeze-drying. Mannitol is the most common of those in lyophilised injectable formulations^[7]. Different products carry different loads of all three, so two vials really do have slightly different freezing points. Slightly is the word: fractions of a degree, not the several degrees needed to explain one vial solid and one liquid.

Ice nucleation is a lottery, and that is the real answer

Water does not freeze the moment it reaches its freezing point. It supercools, sometimes by many degrees, and then waits for a nucleation event to start the ice. That event is stochastic. Searles, Carpenter and Randolph showed in 2001 that in vials frozen on a temperature-controlled shelf the nucleation temperature "is not under direct control, and its stochastic nature and sensitivity to difficult-to-control parameters result in drying rate heterogeneity"^[2]. A 2024 study by Pisano and colleagues put it more plainly still: nucleation "introduces variability in freezing behavior among vials, even when their thermal environment is identical"^[3]. That study also found that neighbouring vials interact thermally, so one vial freezing can delay the nucleation of the vial beside it^[3].

This is the part worth sitting with. Manufacturers using matched vials, matched fill volumes and a controlled shelf still cannot make a whole batch nucleate at one temperature. A bar fridge holding mixed vial sizes at different fill heights and different distances from the cooling plate will not do better. Whichever vial had the right particulate or the coldest spot in the case went first. The other two were probably still supercooled liquid when the door opened.

Powder and solution are two different problems

An unreconstituted vial has almost nothing to freeze. Lyophilisation works by freezing the solution and then removing the ice by sublimation during primary drying, which leaves a dry cake behind^[2][4]. No bulk water is left to turn back into ice, so a sealed powder vial in a too-cold fridge gets cold without going solid. Grey-market vials of TB-500 and CJC-1295 and PT-141 ship in this state for the same reason. A reconstituted vial is the opposite case: it is mostly water, and water is exactly what freezes.

What a freeze actually does to a peptide

Bhatnagar, Bogner and Pikal separate freezing damage into three stresses: low temperature itself, freeze-concentration as growing ice pushes every solute into a shrinking liquid fraction, and the ice surface^[4]. Freeze-concentration is the one that catches people out, because buffer salts can crystallise out of that concentrating liquid unevenly. In sodium phosphate buffers, selective crystallisation of the disodium salt has been measured producing a pH drop of as much as three units in the freeze concentrate^[5]. A solution formulated at neutral pH can spend its frozen hours somewhere near pH 4.

The ice surface adds aggregation. Dao and colleagues reported in 2024 that removing dissolved air and nanobubbles from a bovine IgG solution before freezing cut subvisible particle counts after thawing from roughly 40,000 to roughly 6,000 per mL^[6]. Two caveats belong here. Nearly all of this literature is about proteins, and a 15-residue peptide has far less folded structure to lose than an antibody does. And none of it was run on BPC-157, GHK-Cu or retatrutide, so the honest position is that the mechanisms apply and the magnitudes are unmeasured for these specific compounds.

What an approved peptide label says about a freeze

There is one place this question has a settled answer, and it is on the licensed side of the line. Teriparatide (Forteo) is a 34-amino-acid peptide sold as a refrigerated solution. Its label instructs storage "under refrigeration at 2° to 8°C (36° to 46°F) at all times except when administering the product", then states: "Do not freeze. Do not use FORTEO if it has been frozen." A frozen device is to be thrown away and replaced^[8]. Refrigerated semaglutide and tirzepatide products carry the same shape of instruction.

That is a manufacturer holding real stability data and deciding a frozen unit is not worth the risk. Nothing equivalent exists for the vials in the thread. Retatrutide is investigational and BPC-157 has no marketing authorisation anywhere we cover, so there is no label, no stability dossier and no manufacturer to write to. See the BPC-157 regulatory summary, the retatrutide status page, and the country pages for the United States, the United Kingdom and Germany.

Where this lands

One vial froze and two did not because ice nucleation is a coin toss each vial throws separately, not because BPC-157 has a property the others lack. Composition contributes a fraction of a degree; chance and thermal position contribute the rest. The poster said they intended to discard the frozen vial, which is the same call an approved peptide's label tells patients to make. We do not advise on handling or using any unapproved substance, and questions about a specific product belong with a healthcare provider.